Jump to:

Bliley Lorillard

[Handwritten CTR Meeting Notes - 1/31/69]

Date: 31 Jan 1969
Length: 2 pages
00619155-00619156
Jump To Images
bliley_lor 00619155-00619156

Abstract

Consists of handwritten meeting notes from Council for Tobacco Research (CTR). Covers budgetary matters for specific projects and the CTR in general. Mentions change in CTR funding practices - "More towards monitored & planned research. Staff & SAB (Scientific Advisory Board) to [be] closely followed. [...] Transition period from grants in aid". Notes Hubner's study acknowledges "bivalent nature of nicotine - pep-up & tranquilizer".

Fields

Rank
1
Company
Council for Tobacco Research
Type
NOTES
Author
#826 (Grant, P.R.)
Recipient
File
Named Person
Hartnett, Timothy V. (B&W exec)
Defense
Little, Arthur D. (Arthur Little died in the 1930s. References to Arthur D. Lit)
Defense
Hubner
Hockett, Robert Casad, Ph.D. (CTR Scientific Director)
Scientific Director of the Council for Tobacco Research from 1972-1974 (WSJ 2/11/93; Allman complaint). Bio-Research Institute BRI conducted a study for the CTR. When Syrian hamsters were exposed to smoke twice a day for 59 to 80 weeks, 40% of those of a cancer-susceptible strain and 4% of a resistant strain developed malignant tumors (WSJ 2/11/93). Before publishing the study in 1974, BRI's founder, Frederic Homberger, sent a manuscript to Robert Hockett, then scientific director of the CTR. Dr. Homberger says he had to do so because halfway through his study, the CTR had changed it from a grant to a contract so they could control publication. They were quite open about that (WSJ 2/11/94. Soon thereafter, Hockett and CTR lawyer Edwin Jacob went to Dr. Homburger's summer house in Maine. Hockett and Jacob did not want BRI to call anything cancer, they wanted it to be "pseudo-epitheliomatous hyperplasis," a euphemism for lesions preceding cancer (WSJ 2/11/93). Dr. Homberger said no, this is not right, it is cancer. Jacob told Dr. Homberger that BRI would never get a penny more if the paper was published without the changes. At the last minute, Dr. Homberger changed the final proofs to read "microinvasive" cancer, a microscopic malignancy. Nevertheless, BRI was never funded by the CTR again (WSJ 2/11/96) Hochett made a statement, as scientific director of the CTR circa February 1972 that neither tobacco and health research in general, nor that of the Council for Tobacco Research has established that tobacco use or cigarette smoking in particular is a major health hazard (Allman complaint, pp. 41-42). Robert C. Hockett was Scientific Director, Vice President and Research Director of CTR. See Bio-Research Institute, TTLA Almanac - Names. (N.M.'s CTR Who's Who)
Named Organization
Council for Tobacco Research - USA (CTR) (Formerly Tobacco Industry Research Committee (TIRC))
Originally organized as the Tobacco Industry Research Committe(TIRC) in 1954, and renamed Council for Tobacco Research - USA, Inc. (CTR) in 1964.
*Scientific Advisory Board (SAB) (Only use SAB with name of specific org.)
Keyword
Twins Studies
Viruses
Thesaurus Term
gene or genome
research activity
expenditure
inhalation study
epidemiology
nicotine
cardiovascular disease
Cardiovascular Effects (Health Effects)

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: 00619155
---
Page 2: 00619156
.,Z

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: